• Citer

Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

par Quivy, Vincent ;Adam, Emmanuelle ;Collette, Yves;Demonte, Dominique ;Chariot, Alain;Vanhulle, Caroline ;Berkhout, Ben;Castellano, Rémy;De Launoit, Yvan ;Burny, Arsène ;Piette, Jacques;Bours, Vincent;Van Lint, Carine
Référence Journal of virology, 76, 21, page (11091-11103)
Publication Publié, 2002

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Auteur:	Quivy, Vincent; Adam, Emmanuelle; Collette, Yves; Demonte, Dominique; Chariot, Alain; Vanhulle, Caroline; Berkhout, Ben; Castellano, Rémy; De Launoit, Yvan; Burny, Arsène; Piette, Jacques; Bours, Vincent; Van Lint, Carine
Informations sur la publication:	Journal of virology, 76, 21, page (11091-11103)
Statut de publication:	Publié, 2002
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Acetylation
	Butyrates -- pharmacology
	Cell Line
	Cell Nucleus -- metabolism
	Cytoplasm -- metabolism
	DNA -- metabolism
	DNA-Binding Proteins -- metabolism
	Gene Expression Regulation, Viral
	HIV Infections -- drug therapy
	HIV Long Terminal Repeat
	HIV-1 -- genetics
	Histone Deacetylase Inhibitors
	Humans
	Hydroxamic Acids -- pharmacology
	I-kappa B Proteins
	Mutagenesis
	NF-kappa B -- antagonists & inhibitors
	NF-kappa B -- genetics
	NF-kappa B -- metabolism
	NF-kappa B p50 Subunit
	Transcription Factor RelA
	Transcriptional Activation
	Tumor Necrosis Factor-alpha -- pharmacology
	U937 Cells
	Virus Latency
	Virus Replication -- drug effects
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0022-538X
	info:pmid/12368351
	PMC136606